CCL2 and breast carcinoma: By cooperating with DNMT1, EZH2 knockdown led to DNA demethylation and consequently upregulated miR-124-3p, which suppressed its target CCL2 expression in breast cancer cells, leading to TAMs M2 polarization restraint.